Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).
D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011897:Random Allocation; D012397:Rosette Formation; D012882:Skin Tests
D001500:BCG Vaccine